Search Weight Loss Topics: |
How to recognize and stop elder abuse in the COVID Era – shorelinemedia.net
Dear Savvy Senior,
Can you write a column on how to recognize elder abuse and what to do if you suspect it?
Concerned Relative
Dear Concerned,
Elder abuse is a big problem in the United States that has escalated during the COVID-19 pandemic. According to the National Council on Aging, as many as 5 million seniors are victims of abuse each year, but studies suggest this crime is significantly under-reported. Only 1-in-14 cases of elder abuse ever get reported to the authorities because victims are usually too afraid, too embarrassed, too helpless or too trusting to call for help.
The term elder abuse is defined as intentional or negligent acts by a caregiver or trusted individual that causes or can cause harm to a vulnerable senior. Elder abuse also comes in many different forms: emotional, psychological, physical or sexual abuse, abandonment, neglect and self-neglect, and financial exploitation.
Those most vulnerable are seniors that are ill, frail, disabled, socially isolated or mentally impaired due to dementia or Alzheimers disease.
Its also important to know that while elder abuse does happen in nursing homes and other long-term care facilities, the vast majority of incidents take place at home where the senior lives. And tragically, the abusers are most often their own family members (usually the victims adult child or spouse) or caregiver.
How to Recognize Abuse
So, how can you tell if an elderly relative or friend is being abused, and what can you do to help?
A change in general behavior is a universal warning sign that a problem exists. If you notice that your relative or friend has become very depressed, withdrawn or gets upset or agitated easily, you need to start asking questions. Here are some additional warning signs on the different types of elder abuse that can help you spot a possible problem.
Physical or sexual abuse: Suspicious bruises or other injuries that cant be explained. Sudden changes in behavior (upset, withdrawn, fearful). Broken eyeglasses. Caregivers refusal to allow visitors to see an elder alone.
Neglect or self-neglect: Weight loss, poor hygiene, unattended medical needs, and unsanitary, unsafe living conditions.
Emotional or psychological abuse: The senior is extremely upset, agitated, withdrawn, unresponsive, fearful or depressed, or demonstrates some other unusual behavior.
Financial exploitation: Missing money or valuables. Unexplained withdrawals from bank accounts, or transfers between accounts. Unauthorized use of credit, debit or ATM card. Unpaid bills despite available funds. Checks written as a loan or gift. Abrupt changes in a will or other documents.
For more tips on how to recognize the warning signs of abuse during the pandemic, see the National Center on Elder Abuse website at NCEA.acl.gov/Resources/COVID-19.aspx.
What to Do
The best ways to help stop elder abuse is to be in touch and keep the lines of communication open. If you suspect any type of abuse or neglect in your relatives or friends home, report it to your local protective services agency.
Adult Protective Services is the government agency responsible for investigating elder abuse cases and providing help and guidance. Call the Eldercare Locator at 800-677-1116 to get the agency contact number in your area or visit NCEA.acl.gov/Resources/State.aspx.
The agency will ask what you observed, who was involved, and who they can contact to learn more. You dont need to prove that abuse is occurring; it is up to the professional.
Or, to report suspected abuse in a nursing home or assisted living facility, call the local Long-Term Care Ombudsman see LTCombudsman.org for contact information.
If, however, you feel the person is in immediate danger, call 911 or the local police for immediate help.
Send your senior questions to: Savvy Senior, P.O. Box 5443, Norman, OK 73070, or visit SavvySenior.org. Jim Miller is a contributor to the NBC Today show and author of The Savvy Senior book.
Read the original here:
How to recognize and stop elder abuse in the COVID Era - shorelinemedia.net
Allakos Announces Publication of Results from the Phase 2 Study of Lirentelimab (AK002) in Patients with Eosinophilic Gastritis and/or Eosinophilic…
DetailsCategory: AntibodiesPublished on Thursday, 22 October 2020 09:27Hits: 394
REDWOOD CITY, CA, USA I October 21, 2020 I Allakos Inc. (Nasdaq: ALLK), a biotechnology company developing lirentelimab (AK002) for the treatment of eosinophil and mast cell-related diseases, today announced the publication of results from the multicenter, randomized, double-blind, placebo-controlled Phase 2 study of lirentelimab (AK002) in patients with eosinophilic gastritis and/or eosinophilic duodenitis (ENIGMA) in the New England Journal of Medicine (NEJM). All AK002 dose arms showed clinically meaningful and statistically significant benefits compared to placebo on all prespecified primary and secondary endpoints, including gastrointestinal tissue eosinophil counts and patient-reported disease symptoms. Previously announced, top-line data from the study are available here. The peer-reviewed article, Anti-Siglec-8 Antibody for Eosinophilic Gastritis and Duodenitis, will also appear in the journals print issue.
About Eosinophilic Gastritis, Eosinophilic Duodenitis, and Eosinophilic Esophagitis
Eosinophilic gastritis, eosinophilic duodenitis (previously referred to as eosinophilic gastroenteritis), and eosinophilic esophagitis are severe inflammatory orphan diseases characterized by the presence of high levels of eosinophils in the stomach, duodenum, or esophagus, respectively. Common symptoms of the diseases include severe abdominal pain, nausea, diarrhea, bloating, cramping, early satiety, loss of appetite, vomiting, dysphagia, and weight loss. The current estimated prevalence of eosinophilic gastritis and eosinophilic duodenitis inthe United Statesis approximately 50,000 people. The estimated prevalence of eosinophilic esophagitis inthe United Statesis approximately 150,000 people. The Company believes that these diseases may be significantly under-diagnosed, or misdiagnosed, as other gastrointestinal diseases. There are no treatments approved specifically for these diseases. Treatment with systemic steroids can provide symptomatic improvement, but long-term treatment with steroids is generally not possible due to the numerous side effects.Allakoshas received orphan drug designation for lirentelimab in eosinophilic gastritis, eosinophilic gastroenteritis, and eosinophilic esophagitis.
AboutAllakos
Allakosis a clinical-stage biotechnology company developing antibodies that target immunomodulatory receptors present on immune effector cells involved in allergic, inflammatory, and proliferative diseases. The Companys lead antibody, lirentelimab (AK002), is being evaluated in a Phase 3 study in eosinophilic gastritis (EG) and/or eosinophilic duodenitis (EoD) and a Phase 2/3 study in eosinophilic esophagitis (EoE). Lirentelimabtargets Siglec-8, an inhibitory receptor selectively expressed on human mast cells and eosinophils. Inappropriately activated eosinophils and mast cells have been identified as key drivers in a number of severe diseases affecting the gastrointestinal tract, eyes, skin, lungs and other organs. Lirentelimab has been tested in multiple clinical studies, in which lirentelimab eliminated blood and tissue eosinophils, inhibited mast cells and improved disease symptoms in patients with EG and/or EoD, EoE, mast cell gastrointestinal disease, severe allergic conjunctivitis, chronic urticaria and indolent systemic mastocytosis.For more information, please visit the Company's website at http://www.allakos.com.
SOURCE: Allakos
Originally posted here:
Allakos Announces Publication of Results from the Phase 2 Study of Lirentelimab (AK002) in Patients with Eosinophilic Gastritis and/or Eosinophilic...
Enteral Feeding Tubes Market revenue to cross USD 3 Bn by 2026: Global Market Insights, Inc. – PRNewswire
SELBYVILLE, Del., Oct. 22, 2020 /PRNewswire/ -- According to latest report "Enteral Feeding Tubes Market Product (Nasoenteric/Nasal Feeding Tube, Abdominal/Ostotomy Feeding Tube), Disease Condition (Cancer, Central Nervous System & Mental Health, Non-malignant Gastrointestinal Disorders), Patient (Adult, Pediatric), Tube Type (Short-Term Feeding Tube, Long-Term Feeding Tube, Temporary Feeding Tube), Tube Placement (Without Surgery, Surgical Placement, Endoscopic Placement), End-use (Home Care, Hospitals), Regional Outlook, Price Trends, Competitive Market Share & Forecast 2026,"by Global Market Insights, Inc., the market valuation of enteral feeding tubeswill cross $3 billion by 2026.
Recent technological advancements have led to higher adoption of enteral feeding devices. The advancements, including bright orange or purple tubing (striped and solid), "enteral only" labels, and manufacturer-specific enteral-only or non-IV compatible connectors, have led to increase in number of consumers opting for enteral feeding tubes. The Global Enteral Device Supplier Association (GEDSA)introduced new enteral connectors (EnFit), conforming to ISO standards for improvement of patient safety and reducing the incidences of medical device tubing misconnections. Moreover, initial G-tube placement performed using a surgical G-tube has been increasingly accepted lately, leading to better customer satisfaction.
Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/4846
Rise in prevalence of metabolic disorders will propel the enteral feeding tubes market growth through 2026. Patients suffering with metabolic disorders need enteral feeding to meet nutritional requirements. As per the statistics published by the International Diabetes Foundation in 2019, the global incidence of diabetes is expected to increase from 463 million in 2019 to 578 million by 2030. Thus, high-protein formulas specific to diabetes are administered through enteral feeding tubes, thereby reducing the need for insulin. Patients with metabolic disorders such as Gaucher disease also need enteral feeding through gastric tubes. Increasing cases of children suffering with metabolic disorders requiring enteral feeding will drive the market demand.
The nasoenteric feeding tube segment in the enteral feeding tubes market is anticipated to witness around 6.1% growth rate till 2026. The patients suffering with swallowing disorders require enteral feeding through nasoenteric feeding tube. Placement of these tubes does not require surgery and is cost-effective in comparison to other feeding tubes. These tubes can be replaced in a shorter period of time.
The cancer segment valued at over USD 900 million revenue in 2019 and is projected to expand at a CAGR of more than 7.6% during 220 to 2026. Cancer patients require safer delivery of nutrition to avoid infection or sepsis. Additionally, providing clinical nutrition to patients through these tubes is preferred to treat weight loss and malnutrition.
The enteral feeding tubes market from pediatric segment is poised to expand at 6.1% CAGR till 2026 propelled by the rising number of pre-mature births with short or long-term morbidity and neonatal mortality due to poor perinatal outcomes. In addition, infants, children and adolescents with physical disabilities require the support of enteral nutrition. According to a published report, there are more than 350 diseases that require tube feeding in children. Nutritional therapy in pediatric population suffering with acute neurological disorders has also augmented the demand for enteral feeding tubes.
The short term feeding tube segment revenue surpassed USD 1,170 million in 2019 and is estimated to attain 6.2% CAGR through 2026 led by the benefits such as replacement of tubes in shorter period of time and placement of these tubes does not require surgery, thereby making the procedure cost-effective.
Without patients needing surgery for tube placement, the enteral feeding tubes market will showcase growth of 6.1% up to 2026 on account of increasing adoption of nasoenteric feeding tubes. Rise in adoption of procedures that do not require surgery such as endoscopic transnasal tube placement will enhance the market value. Tube placement through surgical and endoscopic is expensive than non-surgical tube placement.
The enteral feeding tubes market for hospital end-use segment is predicted to show a reasonable growth of around 6.1% till 2026 impelled by the transposition to enteral nutrition from parenteral nutrition, leading to an increased demand for enteral feeding tubes. Furthermore, the rise in usage of advanced enteral feeding devices and strong presence of hospitals with all facilities in developed countries has led to increased adoption of enteral feeding by hospitals. Moreover, growing expenditure by government authorities on hospitals coupled with presence of trained professionals has fueled the demand for enteral feeding.
China dominated the Asia Pacific enteral feeding tubes market share and revenue exceeded USD 180 million in 2019 driven by rising prevalence of lifestyle diseases in the region. With use of small-bore connectors for connecting the feeding tubes to prevent life-threatening diseases, demand for enteral feeding tubes has increased.
Some of the major players operating in the enteral feeding tubes market include Abbott, Applied Medical Technology, Inc., Avanos, B. Braun, Boston Scientific, C.R. Bard, Cardinal Health, Conmed, Cook Medical and Fresenius Kabi. These players are adopting strategic acquisitions, mergers, colorations and partnerships in order to launch new products and strengthen their industrial position.
Request for customization of this research report @
https://www.gminsights.com/roc/4846
Table of Contents (ToC) of the report:
Chapter 3Enteral Feeding Tubes Market Insights
3.1 Industry segmentation
3.2 Industry landscape, 2015 - 2026 (USD Million)
3.3 Industry impact factors
3.3.1 Growth drivers
3.3.2 Industry pitfalls & challenges
3.4 Growth potential analysis
3.5 COVID-19 impact analysis
3.6 Regulatory landscape
3.7 Porter's analysis
3.8 Competitive landscape, 2019
3.8.1 Competitive matrix analysis
3.9 PESTEL analysis
Browse Complete Table of Contents (ToC) @
https://www.gminsights.com/toc/detail/enteral-feeding-tubes-market
About Global Market Insights, Inc.
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy, and biotechnology.
Contact Us:
Arun HegdeCorporate Sales, USAGlobal Market Insights, Inc.Phone:1-302-846-7766Toll Free:1-888-689-0688Email:[emailprotected]
Related Images
enteral-feeding-tubes-market.png Enteral Feeding Tubes Market Growth Predicted at 6% Through 2026: GMI Some of the major enteral feeding tubes market players include Abbott, Applied Medical Technology, Inc., Avanos, B. Braun, Boston Scientific, C.R. Bard, Cardinal Health, Conmed, Cook Medical and Fresenius Kabi.
Related Links
Enteral Feeding Devices Market
Parenteral Nutrition Market
SOURCE Global Market Insights, Inc.
Read the rest here:
Enteral Feeding Tubes Market revenue to cross USD 3 Bn by 2026: Global Market Insights, Inc. - PRNewswire
Another Reason to Stop the PPI: Clinician Debate – Medscape
Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center.
Recently, I posted a case drawn from my own clinical practice that involved a 60-year-old woman with gastroesophageal reflux disease (GERD). She has been taking a daily dose of a proton pump inhibitor (PPI) for years, with admitted symptom improvement. She now wishes to stop because of her concern that the drug increased her risk for COVID-19. My advice was to stop the PPI, but not because of COVID risk.
This case elicited a number of comments and ideas for which I extend my thanks!
This case was controversial, although the patient's risk for COVID-19 as a result of taking a PPI was clearly not the main theme of the conversation around the case. On that score, I agree with readers who emphasized that routine mitigation strategies, such as hand hygiene and physical distancing, are her most effective means to prevent COVID-19. Given our current state of knowledge, management of chronic medications is not as critical in reducing risk.
Most of the conversation focused on two things: the role of PPIs in GERD and need to rule out other potentially treatable conditions that might explain Virginia's GERD. I see patients like Virginia routinely, and it sounds like many of you do as well. Virginia was taking omeprazole 40 mg twice a day and, like many of you, I wondered why her previous clinician had elected to prescribe such a high dose. A fresh clinical perspective on a long-standing case can be helpful to see opportunities for improvement in care. Reevaluating the need to carry over an unnecessary PPI is a potential area for improvement. It is worthwhile to address this issue with more history and shared decision-making.
Her case provided some clues that there are steps other than PPIs or other acid-suppressing therapy that might improve her GERD symptoms. In addition to her PPI, Virginia was also taking frequent naproxen to treat her knee osteoarthritis. Oral nonsteroidal anti-inflammatory drugs (NSAIDs) are implicated in worsening GERD, and considering a different form of treatment, such as acetaminophen and/or a topical NSAID, can be beneficial for patients in the long term. In contrast, looking for Helicobacter pylori as a potential etiology for her GERD does not seem to be necessary because treating for this infection is not likely to improve GERD.
Most comments focused on the potential for weight loss to improve this patient's GERD. There were, maybe understandably, those who expressed doubt that she could accomplish meaningful weight loss. Of course, losing weight is one of the most difficult objectives for many patients, and it can be a source of severe frustration for patient and clinician alike.
But that rationale should not be a reason to ignore weight loss as an important goal among adults with obesity, even at age 60 years. In a clinical trial of a phased behavioral weight loss intervention among adults with cardiovascular risk factors, fully two thirds of participants who were aged 60 years or older were able to lose at least 4 kg during the 6-month trial. This compared favorably with adults aged 50 years or younger, half of whom lost a comparable amount of weight. Older adults were also more likely to maintain their weight loss compared with younger adults during the 30-month follow-up period.
This patient, worried about her risk for COVID, may be motivated to lose weight knowing that obesity is associated with a higher risk for complications from the disease. This could be a good point to note when initiating a behavioral weight loss program. But her expectations should be tempered, and any intervention to address weight should be realistic and able to be maintained long term. A crash weight loss program is unlikely to be either healthy or successful.
For this patient, the issue of bone health must be considered when advising weight loss as excessive weight loss might reduce bone density. However, the benefits of weight loss, as noted in multiple comments, will extend beyond probable improvement in her GERD. That makes this issue worth revisiting and certainly as least as important as her PPI therapy.
And let's not forget the reason she wanted to stop the PPI in the first place her fear that it increased her risk for COVID. Although we don't have a definitive answer yet, it certainly appears that another benefit of discontinuing her PPI may well be that it reduces her risk for COVID-19. Clinical inertia in this case is a missed opportunity to reduce her burden of medications while improving her long-term health.
Charles P. Vega, MD, is a clinical professor of family medicine at UC Irvine and also serves as the UCI School of Medicine assistant dean for culture and community education. He focuses on medical education with an intent to resolve health disparities.
Follow Medscape on Facebook, Twitter, Instagram, and YouTube
Excerpt from:
Another Reason to Stop the PPI: Clinician Debate - Medscape
Global Weight Loss & Weight Management Market 2020 Projections & Future Opportunities Recorded for the Forecast Period to 2026 – The Think…
The newly added research report on global Weight Loss & Weight Management market presents a thorough analytical assessment pertaining to elaborate trend analysis, overall industry expansion initiatives, besides also harping at length on regional growth prospects and holistic competitive landscape.
Further in the report, readers are also guided about the current developments in the competitive landscape with in-depth references of industry players displaying a strong footing in the competitive landscape.
For Sample Copy of Reports: https://www.adroitmarketresearch.com/contacts/request-sample/859?utm_source=Bhagyashri
The report is an extensive portrayal of the current market scenario defining opportunity prospects in lucid details. Factors such as latency value and futuristic potential of teeming opportunities have been closely monitored and featured in this section of the report on global Weight Loss & Weight Management market.
Additional details in the realms of prominent challenges and market threats have also been well evaluated to render a complete barrier analysis review of the Weight Loss & Weight Management market based on which market aspirants, industry stalwarts as well as other relevant contributors and prominent market investors can chalk down and implement prompt business decisions to foster long term stability and incessant revenue chains under challenging circumstances in global Weight Loss & Weight Management market.
Complying with the existing challenges and growth deterrents such as the recent pandemic crisis that has significantly stunned high potential growth in the global Weight Loss & Weight Management market, this intricately designed business intelligence report is expected to trigger future ready business decisions, complete with a thorough pandemic management guide. The following is a gist of COVID-19 implications upon businesses in recent times.
The report has analyzed several players in the market, some of which include:
BRUNSWICK CORPORATION, Nutrisystem, Inc., Amer Sports, Covidien plc (Wholly-Owned Subsidiary of Medtronic PLC), HERBALIFE NUTRITION LTD., Johnson Health Tech. Co. Ltd., Technogym S.p.A, Apollo Endosurgery, Inc., WW International, Inc., eDiets.Com Inc., Kellogg Co., Jenny Craig, Inc., Ethicon, Inc. (A Subsidiary of Johnson & Johnson) and GOLDS GYM
Read complete report at: https://www.adroitmarketresearch.com/industry-reports/weight-loss-and-weight-management-market?utm_source=Bhagyashri
3-Pointer Evaluation of COVID-19 Impact
1. The report renders a thoroughly evaluated market outlook of the world perspective and the overall economic overview2. Stark differences and alterations in demand and supply chains have been highlighted3. A crisp pre and post COVID-19 developments and beyond have also been tagged in this corporate report on global Weight Loss & Weight Management market.
Global Weight Loss & Weight Management market is segmented based by type, application and region.
Market by Types
by Equipment (Surgical Equipment {Noninvasive surgical equipment and Minimally invasive surgical equipment}, Fitness Equipment{ Strength training equipment, Body Composition Analyzers, Fitness Monitoring Equipment, and Cardiovascular training equipment); by Service (Slimming Centers and Commercial Weight Loss Centers, Online Weight Loss Programs, Fitness Centers and Health Clubs, and Consulting Services); by Diet (Beverages, Meals, and Supplements)
Market by Application
NA
An Overview of Regional Developments: Global Weight Loss & Weight Management Market
1. The overall spectrum of the global Weight Loss & Weight Management market is broadly diversified into North and South America, Europe, APAC, and MEA.2. The report gauges into vital details such as manufacturer performance and overall growth activities across potent growth hubs.3. A close review of the overall growth rate during both past and current timelines have been meticulously highlighted to encourage thoughtful business decisions in global Weight Loss & Weight Management market4. A clear reference of the overall revenue generation, sales performance as well as growth rate synopsis have been thoroughly structured in this versatile research report on global Weight Loss & Weight Management market.5. Further in the report, readers are presented with substantia, cues on vendor landscape, frontline players and their company profiles and performance analysis have all been optimally highlighted in this report to encourage adequate reader discretion.
Ask to our industry expert at: https://www.adroitmarketresearch.com/contacts/enquiry-before-buying/859?utm_source=Bhagyashri
About Us :
Adroit Market Research is an India-based business analytics and consulting company incorporated in 2018. Our target audience is a wide range of corporations, manufacturing companies, product/technology development institutions and industry associations that require understanding of a markets size, key trends, participants and future outlook of an industry. We intend to become our clients knowledge partner and provide them with valuable market insights to help create opportunities that increase their revenues. We follow a code Explore, Learn and Transform. At our core, we are curious people who love to identify and understand industry patterns, create an insightful study around our findings and churn out money-making roadmaps.
Contact Us :
Ryan JohnsonAccount Manager Global3131 McKinney Ave Ste 600, Dallas,TX75204, U.S.A.Phone No.: USA: +1 972-362 -8199/ +91 9665341414
View original post here:
Global Weight Loss & Weight Management Market 2020 Projections & Future Opportunities Recorded for the Forecast Period to 2026 - The Think...
Future Growth Of Weight Loss and Obesity Management Market By New Business Developments, Innovations, And Top Companies Forecast To 2025 – Express…
The global Weight Loss and Obesity Management Market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Weight Loss and Obesity Management market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global Weight Loss and Obesity Management market. With qualitative and quantitative analysis, we help you with thorough and comprehensive research on the global Weight Loss and Obesity Management market. We have also focused on SWOT, PESTLE, and Porters Five Forces analyses of the global Weight Loss and Obesity Management market.
The research report on Weight Loss and Obesity Management market elaborates on the major trends defining the industry growth with regards to the regional terrain and competitive scenario. The document also lists out the limitations & challenges faced by industry participants alongside information such as growth opportunities. Apart from this, the report contains information regarding the impact of COVID-19 pandemic on the overall market outlook.
Key insights from COVID-19 impact analysis:
Request Sample Copy of this Report @ https://www.express-journal.com/request-sample/219165
An overview of regional landscape:
Additional information from the Weight Loss and Obesity Management market report:
Table of Contents
Request Customization on This Report @ https://www.express-journal.com/request-for-customization/219165
View original post here:
Future Growth Of Weight Loss and Obesity Management Market By New Business Developments, Innovations, And Top Companies Forecast To 2025 - Express...
COLUMN: Connection matters now more than ever | Opinion – Montrose Daily Press
Connection matters now more than ever. There is no one who hasnt been touched by this pandemic. Staying home, avoidance of friends and group meetings, socially distancing ourselves, and the masks are all inconveniences to be tolerated for the greater good.
Yet, there is one group that has not had the touch or connection from their loved ones or even the liberty of going to the grocery store. In March, the Center for Medicare and Medicaid Services (CMS) took the unprecedented step of removing visitation to skilled nursing and assisted living facilities by all family, friends and community members.
I want to stress unprecedented because since the beginning of the Older Americans Act and the Ombudsman Program, residents rights have been promoted and protected under law. The federal Nursing Home Reform Law requires nursing homes to promote and protect the rights of each resident and stresses individual dignity and self-determination including the right to access visitors of his or her choosing, at any time.
It soon became apparent that there were unintended consequences of removing visitors to spare our most vulnerable from possible exposure to the virus. Within two months, this ombudsman was hearing of the rise in resident depression scores, loss of hope, confusion, weight loss, incontinence and decline. The incidence of resident to resident assaults, expressions of desire to die, feelings of being in jail, anger and frustration have been reported to me and other ombudsmen across the nation.
The brunt of resident emotional support has fallen to our much beleaguered long-term care workers. They have done their best to fill in for families and visitors in addition to attending to all care needs.
Your ombudsman program recognized early in this crisis that virtual resident contact and communication needed to be made a priority and supplied all facilities in our region with an iPad tablet. Residents and families have used the device to stay connected, celebrate milestone birthdays, see new grandchildren and connect with their physician. Community-wide efforts to visit residents through windows made the isolation somewhat bearable. Community members, churches, organizations, individuals have all worked to cheer and lessen isolation. Thank you to each of you who reached out to make a difference to our elders!
Recognizing the suffering by residents and their families, the ombudsman program has worked to bring awareness and promote resident interests at a systemic level.
The Colorado State Ombudsman has relayed reports from local ombudsmen about the effect of isolation to state government. By June, the governors strike force team, had released a policy allowing for socially distanced outside visits so that residents could connect with friends and family.
The same task force recently released through ombudsman advocacy and in anticipation of our cooler Colorado weather, an indoor visitation policy. There are some critical factors tied to indoor visits; community case rates. In counties with a 14-day case rate of less than or equal to 25 new active cases there are no testing requirements for visitors. When the case rate rises to greater than 26, visitors must provide documentation of a negative COVID-19 test within 48 hours preceding the visit.
Residents Rights Month is held every October. This years theme, Connection Matters, emphasizes connections to family, to friends and to the community as an essential component of good health and quality of life for residents. The months of restrictions on visitation in long-term care and the inability of residents, families and friends to be together during the pandemic has emphasized the importance of connection, of relationships, and the impact they have on our well-being.
Please take a moment to think of our long-term care residents, make an impact in their lives and be responsible with your actions in our community. It could mean the difference between life and death. Your local ombudsman is available at Region 10/Area Agency on Aging at 970-765-3131.
Sandy Walker is the lead LTC ombudsman at Region 10.
Read the original post:
COLUMN: Connection matters now more than ever | Opinion - Montrose Daily Press
Coronavirus recovery: Most common post-COVID signs which could indicate signs of long term trouble – Times of India
People who have made successful recoveries from COVID are returning to hospitals complaining of discomfort, fullness and cardiac complications, despite having no pre-existing history for heart problems. Some have also been asked to go for preventive screenings in the long run. In fact, incidents of myocardial injuries and infraction are some of the most common post-COVID issues people face and leave lasting damage in the long run.
According to doctors, the heart is one of the most vital organs impacted by COVID, and the implications can be harsh for everyone, no matter what age, severity, immunity or condition they have. At a preliminary level, it may lead to a decrease in heart function. This could be a result of either the systemic inflammatory response to infection or direct viral infection in the heart. Excessive pressure or stress put on the lungs or the heart can also result in myocarditis, which can lead to arrhythmia or even heart failure, in rare cases. Hence, it's important to look out for preventive signs, keep a check on essential vitals and take action accordingly. Making changes to your diet and lifestyle, as part of rehabilitative care should also be paid attention to in the long run.
View original post here:
Coronavirus recovery: Most common post-COVID signs which could indicate signs of long term trouble - Times of India
Lung cancer symptoms: Swelling in a certain body part could be due to the deadly condition – Express
Most lung cancers are caused by smoking tobacco or exposure to second-hand smoke. Symptoms include a persistent cough that lasts for three weeks or more and repeated chest infections. Swelling could be a sign of a further complication.
The Roy Castle Lung Cancer Foundation added further signs of lung cancer to be aware of.
These include breathlessness, chest or shoulder pain, and loss of appetite and/or unexplained weight loss.
Further signs of lung cancer are: coughing up blood, unexplained fatigue or lack of energy, and hoarseness.
Also be on the lookout for finger clubbing, blood clots, a change in a long-term cough, or a cough that gets worse.
The charity reports that there are around "46,000 lung cancer cases each year".
The disease can develop in men and women, young and old, smokers and non-smokers, so it's vital to be aware of the signs.
As there are no pain sensors inside the lungs, "it can be difficult to spot changes until [the cancer] affects other parts of the body".
READ MORE:Bowel cancer symptoms - the sign in your poo you need to watch out for
Tingling feelings in the hands and feet are signs of neuropathy, which can happen when the tumour grows near the nerves in the arm or shoulder.
If lung cancer spreads to another part of the body, it will make treatment more difficult.
This is why it's important to seek medical advice as soon as you notice signs of cancer.
The sooner cancer is treated, the better chances a person has for a full recovery.
To reduce your risk of developing lung cancer, the Roy Castle Lung Cancer Foundation shares some of its tips.
"It is never too late to stop smoking," assured the charity. "There are many immediate and long term benefits to stopping."
Try, as best as possible to "avoid second-hand smoke" it's as risky as smoking yourself.
"A poor diet can also cause lung cancer," it added, so eating "five portions of fruit and vegetables every day" is recommended.
In addition "drink less alcohol", as "the less alcohol you drink, the lower your risk of all cancers".
"Take regular exercise", which can reduce your risk of cancer, as well as boosting your mood, reducing stress and improving energy levels.
Any activity that warms you up counts, such as sports, yoga, swimming, household chores and brisk walking.
The additional bonus of exercising is that it helps to reduce the risk of falls in older adults.
Read more:
Lung cancer symptoms: Swelling in a certain body part could be due to the deadly condition - Express
Is a vegan diet right for you? Heres everything you need to know – TODAY
The word "vegan" may conjure up images of celebrities downing $10 green juice after their Sunday morning yoga class. But the eating plan is much more than another buzzy diet trend. Lizzo is one of the most recent celebs to subscribe to the eating philosophy, not to lose weight or make a political statement, but because she said, "health is what happens on the inside."
And she's right. A vegan diet can be a smart choice for many people; one that can improve your health, prevent or help control a variety of health conditions and yes, it can help you lose weight if that's your goal.
What is a vegan diet exactly? Put simply, it is one where youre not eating animals or foods that come from animals (like eggs, milk, cheese or honey). And while it is restrictive in some ways (especially for those who rely heavily on animal products), it also opens up a world of possibilities when it comes to getting creative with nutrient-dense, plant-based foods.
According to the Academy of Nutrition and Dietetics, vegan eating can be a healthy diet for people of all ages (including children), pregnant and lactating women, and athletes.
The diet may help you:
Research found that compared to eating a low-fat diet, people eating a vegan diet lost more than three times as much weight after two years. Research also suggests that for people with type 2 diabetes, eating vegan may help them better manage their condition, as well as help boost mood and weight loss and lower cholesterol. And since you'll be cutting out foods that are linked to poor health when eaten in excess, like meat, butter and cheese, a vegan diet will promote your health overall.
Data also suggests people who eat vegan, on average, tend to have lower BMIs and be less likely to develop hypertension, type 2 diabetes, and metabolic syndrome compared to non-vegetarians and other types of vegetarians.
But to see those benefits, you need to eat foods that are minimally processed, since they tend to be the most nutrient-dense for the calories, said Gabrielle Turner-McGrievy, PhD, RD, associate professor in the department of Health Promotion, Education and Behavior in the Arnold School of Public Health at University of South Carolina (who studies the health benefits of vegan eating). You can do an unhealthy version of really any diet.
Done correctly, its beneficial for anyone, explained Amy Shapiro, MS, RD, CDN, founder and director of Real Nutrition in New York City. Eating vegan (if youre doing it the healthy way) can benefit people who have heart disease and/or high cholesterol and are looking to reduce the amount of saturated fats in their diets, Shapiro says. It can also help people control diabetes and lose weight, so its a good option for those looking to slim down.
Eating vegan (along with other types of plant-based diets) is also good for the planet. Farming animals for food is known to be one of the big contributors to greenhouse gas emissions that are contributing to climate change. And it can be friendly on your wallet, too, according to another study from Turner-McGrievy and her colleagues. Dried beans and rice are a lot less expensive than beef, she said.
If your plate is currently filled with meat, fish and eggs, start by eating vegan a few times a week. This can make the transition easier, by giving you time to experiment with vegan recipes and slowly shift your mindset to building a meal around plant-based foods.
As long as youre not eating animals or animal products, youre following a vegan diet. But just because a food is vegan doesnt mean its necessarily part of a healthy diet.
Candy, French fries and potato chips can all be vegan, but they also tend to be high in fat and low in fiber, which means they wont fill you up and youre more likely to eat more than a healthy portion, explained Shapiro. A lot of clients come to me who put on weight after going vegan because the quick and easy-to-grab foods arent always so healthy.
Focus on plants and whole foods, the less processed the better, Shapiro said. Get protein from nuts, seeds, beans and other legumes. Eat healthy fats, like avocado, olive oil, nuts and seeds. When it comes to carbohydrates, choose nutrient-dense ones, like whole grains, potatoes, legumes and fresh fruits. Try non-dairy milks and yogurts. And definitely do eat lots of vegetables.
For packaged foods: check the label for ingredients you recognize and can pronounce, Shapiro said.
What a day on a vegan diet may look like:
Wondering what your plate may look like when following a vegan diet? Shapiro broke it down:
Breakfast: Oatmeal with chia seeds, blueberries and cinnamon
Lunch: Large salad of mixed greens, olives, a variety of vegetables, edamame and hemp seeds
Snack: 1/2 cup coconut yogurt mixed with cashews and goji berries
Dinner: Lentil based pasta, tossed with vegan pesto, spinach, broccoli and peas
Dessert: Small scoop vegan ice cream like those made by Daily Harvest or Van Lehwen
The only vitamin youre really missing out on is vitamin B12, which is only found in animals, Shapiro explained. Do consider a supplement, she said.
Other vitamins that you might not be getting enough are iron (plants have iron, but our bodies dont absorb it as well as the type found in animal sources) and zinc (which is found in some, but not all vegetables). Dairy products (which are not vegan) tend to be good sources of calcium and vitamin D, but many dairy alternatives (like nut milks and coconut yogurts) are fortified with these nutrients.
Done right focusing on whole and minimally processed, nutrient-dense foods a vegan diet offers a lot of health benefits for people of all ages and lifestyles. Educate yourself, however, before you start. Consider talking to a dietitian, reading books, stocking your pantry, taking a vegan cooking class or watching some Youtube videos. And as always, start with your doctor, who will be able to recommend the best eating plan for you.
More here:
Is a vegan diet right for you? Heres everything you need to know - TODAY